PlGF and sVEGFR-1 in chronic subdural hematoma: Implications for hematoma development Clinical article

Journal of Neurosurgery

Volumn 118, Issue 2, 2013, Pages 353-357

  Kalamatianos, Theodosis ^a,b   Stavrinou, Lampis C ^a,b   Koutsarnakis, Christos ^a,b   Psachoulia, Christina ^c   Sakas, Damianos E ^a,b   Stranjalis, George ^a,b  

^a Hellenic Centre for Neurosurgical Research Petros Kokkalis   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c EVANGELISMOS HOSPITAL   (Greece)

Author keywords

Angiogenesis; Chronic subdural hematoma; PLGF; SVEGFR 1; Traumatic brain injury; Vascular hemorrhagic disorder

Indexed keywords

PLACENTAL GROWTH FACTOR; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); HEMATOMA; HUMAN; INFLAMMATION; INFLAMMATORY CELL; ISCHEMIA; PRIORITY JOURNAL; SUBDURAL HEMATOMA;

AGED; AGED, 80 AND OVER; BODY FLUIDS; FEMALE; HEMATOMA, SUBDURAL, CHRONIC; HUMANS; LUMINESCENT MEASUREMENTS; MALE; NEOVASCULARIZATION, PATHOLOGIC; PREGNANCY PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84873665764     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2012.10.JNS12327     Document Type: Article

References (48)

1. Adini A, Kornaga T, Firoozbakht F, Benjamin LE: Placental growth factor is a survival factor for tumor endothelial cells and macrophages. Cancer Res 62:2749-2752, 2002.
2. Ahmad S, Hewett PW, Al-Ani B, Sissaoui S, Fujisawa T, Cudmore MJ, et al: Autocrine activity of soluble Flt-1 controls endothelial cell function and angiogenesis. Vasc Cell 3:15, 2011.
3. Autiero M, Waltenberger J, Communi D, Kranz A, Moons L, Lambrechts D, et al: Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med 9:936-943, 2003.
4. Bottomley MJ, Webb NJ, Watson CJ, Holt L, Bukhari M, Denton J, et al: Placenta growth factor (PlGF) induces vascular endothelial growth factor (VEGF) secretion from mononuclear cells and is co-expressed with VEGF in synovial fluid. Clin Exp Immunol 119:182-188, 2000.
5. Cai J, Ahmad S, Jiang WG, Huang J, Kontos CD, Boulton M, et al: Activation of vascular endothelial growth factor receptor- 1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells. Diabetes 52:2959-2968, 2003.
6. Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, et al: Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 7:575-583, 2001.
7. Fischer C, Mazzone M, Jonckx B, Carmeliet P: FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? Nat Rev Cancer 8:942-956, 2008.
8. Foidart JM, Schaaps JP, Chantraine F, Munaut C, Lorquet S: Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia- A step forward but not the definitive answer. J Reprod Immunol 82:106-111, 2009.
9. Foyouzi N, Norwitz ER, Tsen LC, Buhimschi CS, Buhimschi IA: Placental growth factor in the cerebrospinal fluid of women with preeclampsia. Int J Gynaecol Obstet 92:32-37, 2006.
10. Frati A, Salvati M, Mainiero F, Ippoliti F, Rocchi G, Raco A, et al: Inflammation markers and risk factors for recurrence in 35 patients with a posttraumatic chronic subdural hematoma: a prospective study. J Neurosurg 100:24-32, 2004.
11. Friede RL, Schachenmayr W: The origin ofsubdural neomembranes. II. Fine structural of neomembranes. Am J Pathol 92: 69-84, 1978.
12. Fujisawa H, Nomura S, Kajiwara K, Kato S, Fujii M, Suzuki M: Various magnetic resonance imaging patterns of chronic subdural hematomas: indicators of the pathogenesis? Neurol Med Chir (Tokyo) 46:333-339, 2006.
13. Funai M, Osuka K, Usuda N, Atsuzawa K, Inukai T, Yasuda M, et al: Activation of PI3 kinase/Akt signaling in chronic subdural hematoma outer membranes. J Neurotrauma 28:1127-1131, 2011.
14. Green CJ, Lichtlen P, Huynh NT, Yanovsky M, Laderoute KR, Schaffner W, et al: Placenta growth factor gene expression is induced by hypoxia in fibroblasts: a central role for metal transcription factor-1. Cancer Res 61:2696-2703, 2001.
15. Hattori K, Heissig B, Wu Y, Dias S, Tejada R, Ferris B, et al: Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. Nat Med 8:841-849, 2002.
16. Hohenstein A, Erber R, Schilling L, Weigel R: Increased mRNA expression of VEGF within the hematoma and imbalance of angiopoietin-1 and -2 mRNA within the neomembranes of chronic subdural hematoma. J Neurotrauma 22:518-528, 2005.
17. Hong HJ, Kim YJ, Yi HJ, Ko Y, Oh SJ, Kim JM: Role of angiogenic growth factors and inflammatory cytokine on recurrence of chronic subdural hematoma. Surg Neurol 71:161-166, 2009.
18. Karumanchi SA, Bdolah Y: Hypoxia and sFlt-1 in preeclampsia: the "chicken-and-egg" question. Endocrinology 145:4835-4837, 2004.
19. Khaliq A, Foreman D, Ahmed A, Weich H, Gregor Z, McLeod D, et al: Increased expression of placenta growth factor in proliferative diabetic retinopathy. Lab Invest 78:109-116, 1998.
20. Kristof RA, Grimm JM, Stoffel-Wagner B: Cerebrospinal fluid leakage into the subdural space: possible influence on the pathogenesis and recurrence frequency of chronic subdural hematoma and subdural hygroma. J Neurosurg 108:275-280, 2008.
21. Lee KS: Natural history of chronic subdural haematoma. Brain Inj 18:351-358, 2004.
22. Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, Liao F, et al: Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 8:831-840, 2002.
23. Markwalder TM, Reulen HJ: Influence of neomembranous organisation, cortical expansion and subdural pressure on the post-operative course of chronic subdural haematoma-an analysis of 201 cases. Acta Neurochir (Wien) 79:100-106, 1986.
24. Nakaguchi H, Tanishima T, Yoshimasu N: Factors in the natural history of chronic subdural hematomas that influence their postoperative recurrence. J Neurosurg 95:256-262, 2001.
25. Nanko N, Tanikawa M, Mase M, Fujita M, Tateyama H, Miyati T, et al: Involvement of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in the mechanism of development of chronic subdural hematoma. Neurol Med Chir (Tokyo) 49:379-385, 2009.
26. Odorisio T, Schietroma C, Zaccaria ML, Cianfarani F, Tiveron C, Tatangelo L, et al: Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability. J Cell Sci 115:2559-2567, 2002.
27. Oura H, Bertoncini J, Velasco P, Brown LF, Carmeliet P, Detmar M: A critical role of placental growth factor in the induction of inflammation and edema formation. Blood 101:560- 567, 2003.
28. Pan P, Fu H, Zhang L, Huang H, Luo F, Wu W, et al: Angiotensin II upregulates the expression of placental growth factor in human vascular endothelial cells and smooth muscle cells. BMC Cell Biol 11:36, 2010.
29. Pilarczyk K, Sattler KJ, Galili O, Versari D, Olson ML, Meyer FB, et al: Placenta growth factor expression in human atherosclerotic carotid plaques is related to plaque destabilization. Atherosclerosis 196:333-340, 2008.
30. Roeckl W, Hecht D, Sztajer H, Waltenberger J, Yayon A, Weich HA: Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2. Exp Cell Res 241:161-170, 1998.
31. Roncal C, Buysschaert I, Gerdes N, Georgiadou M, Ovchinnikova O, Fischer C, et al: Short-term delivery of anti-PlGF antibody delays progression of atherosclerotic plaques to vulnerable lesions. Cardiovasc Res 86:29-36, 2010.
32. Santarius T, Kirkpatrick PJ, Kolias AG, Hutchinson PJ: Working toward rational and evidence-based treatment of chronic subdural hematoma. Clin Neurosurg 57:112-122, 2010.
33. Sato S, Suzuki J: Ultrastructural observations of the capsule of chronic subdural hematoma in various clinical stages. J Neurosurg 43:569-578, 1975.
34. Schachenmayr W, Friede RL: The origin of subdural neomembranes. I. Fine structure of the dura-arachnoid interface in man. Am J Pathol 92:53-68, 1978.
35. Schiettecatte J, Russcher H, Anckaert E, Mees M, Leeser B, Tirelli AS, et al: Multicenter evaluation of the first automated Elecsys sFlt-1 and PlGF assays in normal pregnancies and preeclampsia. Clin Biochem 43:768-770, 2010.
36. Schoenfeld J, Lessan K, Johnson NA, Charnock-Jones DS, Evans A, Vourvouhaki E, et al: Bioinformatic analysis of primary endothelial cell gene array data illustrated by the analysis of transcriptome changes in endothelial cells exposed to VEGF-A and PlGF. Angiogenesis 7:143-156, 2004.
37. Selvaraj SK, Giri RK, Perelman N, Johnson C, Malik P, Kalra VK: Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor. Blood 102:1515-1524, 2003.
38. Shono T, Inamura T, Morioka T, Matsumoto K, Suzuki SO, Ikezaki K, et al: Vascular endothelial growth factor in chronic subdural haematomas. J Clin Neurosci 8:411-415, 2001.
39. Suzuki K, Takano S, Nose T, Doi M, Ohashi N: Increased concentration of vascular endothelial growth factor (VEGF) in chronic subdural hematoma. J Trauma 46:532-533, 1999.
40. Suzuki M, Endo S, Inada K, Kudo A, Kitakami A, Kuroda K, et al: Inflammatory cytokines locally elevated in chronic subdural haematoma. Acta Neurochir (Wien) 140:51-55, 1998.
41. Weigel R, Hohenstein A, Schlickum L, Weiss C, Schilling L: Angiotensin converting enzyme inhibition for arterial hypertension reduces the risk of recurrence in patients with chronic subdural hematoma possibly by an antiangiogenic mechanism. Neurosurgery 61:788-793, 2007.
42. Weigel R, Schilling L, Schmiedek P: Specific pattern of growth factor distribution in chronic subdural hematoma (CSH): evidence for an angiogenic disease. Acta Neurochir (Wien) 143:811-819, 2001.
43. Wu FT, Stefanini MO, Mac Gabhann F, Kontos CD, Annex BH, Popel AS: A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use. J Cell Mol Med 14:528-552, 2010.
44. Yamamoto H, Hirashima Y, Hamada H, Hayashi N, Origasa H, Endo S: Independent predictors of recurrence of chronic subdural hematoma: results of multivariate analysis performed using a logistic regression model. J Neurosurg 98:1217-1221, 2003.
45. Yamashima T, Yamamoto S, Friede RL: The role of endothelial gap junctions in the enlargement of chronic subdural hematomas. J Neurosurg 59:298-303, 1983.
46. Yonekura H, Sakurai S, Liu X, Migita H, Wang H, Yamagishi S, et al: Placenta growth factor and vascular endothelial growth factor B and C expression in microvascular endothelial cells and pericytes. Implication in autocrine and paracrine regulation of angiogenesis. J Biol Chem 274:35172-35178, 1999.
47. Yoo SA, Yoon HJ, Kim HS, Chae CB, De Falco S, Cho CS, et al: Role of placenta growth factor and its receptor flt-1 in rheumatoid inflammation: a link between angiogenesis and inflammation. Arthritis Rheum 60:345-354, 2009.
48. Ziche M, Maglione D, Ribatti D, Morbidelli L, Lago CT, Battisti M, et al: Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic. Lab Invest 76:517-531, 1997.